Search

ABBOTT TAVI MASTERS WEBINARS 2025 Don't miss our upcoming webinar series for both experienced operators and newcomers to discover and master the world of TAVI. Resgister noW for April 2025 Webina

Therapies Valvular Diseases Mitral Valve Disease Aortic Valve Disease Tricuspid Valvle Disease Paravalvular Leak

SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding LAA Occlusion STROKE RISK REDUCTION AND FREEDOM FROM ANTICOAGULANTS Clinical studies have shown

The objective of this trial is to evaluate the safety and effectiveness of the Amulet™ LAA Occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke an

ON DEMAND Echo Course Webinars 2024 Echo guidance for screening and interventions in structural heart diseases PART 1: ANATOMICAL OVERVIEW ECHO COURSES PART 2: MITRAL-TEER ECHO COURSES PART 3:

ON DEMAND AV VALVES SUMMIT 2024 2nd International edition of the AtrioVentricular Valves Summit DAY 1: TRICUSPID FOCUS DAY 2: MITRAL AND AV VALVES FOCUS © Abbott 2024. All rights reserved. 9-E

Defect size as noted below is presented as a percentage of the aortic annulus diameter. A small VSD of ≤ 25% has small left-to-right shunts and no LV volume overload. These VSDs usually have a very

EXPLORE VSD SOLUTIONS Amplatzer Muscular occluder for ventricular septal defect

When symptoms develop Most children with isolated ASDs are asymptomatic. If patients are untreated, however, symptoms can occur in adulthood.2

EXPLORE ASD SOLUTIONS Amplatzer Septal occluder for ASD closure